Use of Brexucabtagene Autoleucel in the treatment of Relapsed/refractory Mantle Cell Lymphoma. Acervo Saúde [Internet]. 2025 Jun. 13 [cited 2026 Nov. 3];25(6):e20837. Available from: https://acervomais.com.br/saude/article/view/20837